Stay updated on ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial
Sign up to get notified when there's something new on the ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial page.

Latest updates to the ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the terminated ADI-PEG 20 plus FOLFOX trial, with detailed study information for patients and researchers.SummaryDifference64%

- Check17 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide NIH notice appears above the page, announcing a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on an otherwise unchanged 403 Forbidden page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check59 days agoChange DetectedA 403 Forbidden error page now appears, blocking access to the study record content and replacing expected page content with a standard error screen.SummaryDifference18%

Stay in the know with updates to ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial page.